$Syndax制药(SNDX)$ Syndax soars 30% premarket after trial primary endpoint Syndax在临床试验中主要终点达成后,盘前股价飙升30%。来自ChatGPT翻译
发布于: | 雪球 | 转发:0 | 回复:0 | 喜欢:0 |
$Syndax制药(SNDX)$ Syndax soars 30% premarket after trial primary endpoint Syndax在临床试验中主要终点达成后,盘前股价飙升30%。来自ChatGPT翻译